1AI 14.3% 0.8¢ algorae pharmaceuticals limited

Barry Snow described the results of the study as a "Rubiks Cube"...

  1. 16,918 Posts.
    lightbulb Created with Sketch. 2406
    Barry Snow described the results of the study as a "Rubiks Cube" where understanding how the results came about is a puzzle. That is what they are trying to do now, looking at all the characteristics of the individual patients and seeing if it has any relationship to the responses at a given dose. The longer the study time, the more data points they have, the better the chances they have of getting some insight.

    Personally I don't believe they will pursue the PD use of NTcell if they cannot find some reasonable good scioentific evidence of efficacy in the data from the trial over 18-24 months. They would need to see a consistent trend which leads to statistical significance to seek and allocate more funds.
 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
(20min delay)
Last
0.8¢
Change
0.001(14.3%)
Mkt cap ! $13.49M
Open High Low Value Volume
0.8¢ 0.8¢ 0.8¢ $34 4.285K

Buyers (Bids)

No. Vol. Price($)
9 8215316 0.7¢
 

Sellers (Offers)

Price($) Vol. No.
0.8¢ 1837858 8
View Market Depth
Last trade - 10.00am 04/09/2024 (20 minute delay) ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.